PHARMANJE
Timeline
16 events since 2009Board
Capital
Filings
Financial
End
Address
Other
201020122014201620182020202220242026
2017
Merger: absorbed by MULTIPHARMADissolution of the company · Dissolved without liquidation · Books and records kept by MULTIPHARMA · General meeting of 21-12-20165 points ▸
- General meeting of 21-12-2016
- Merger by absorption
- MULTIPHARMA holds all the shares
- The operation takes effect in the accounts on 01-09-2016
- Power of attorney granted to
- The deed holds 2 more points.
2016
Merger proposal: to be absorbed by MULTIPHARMA2 points ▸
- Merger by absorption
- The operation takes effect in the accounts on 01-09-2016
- The deed holds 5 more points.
Registered office moved to AnderlechtThe registered office moved to Square Marie Curie 30 te 1070 Anderlecht · resigns as manager · (manager) and (statutory auditor) appointed · General meeting of 18-04-20167 points ▸
- General meeting of 18-04-2016
- resigns as manager
- Discharge granted to (manager)
- appointed as manager
- The registered office moved to Square Marie Curie 30 te 1070 Anderlecht
- appointed as statutory auditor
- acts as permanent representative
- The deed holds 1 more point.
changes role from statutory manager to managerDischarge granted to (statutory manager) · General meeting of 14-04-20164 points ▸
- General meeting of 14-04-2016
- resigns as statutory manager
- Discharge granted to (statutory manager)
- appointed as manager, not named in the articles
- The deed holds 1 more point.
Annual accounts 2015 filed PDFabbreviated format · 32 days before the deadline
2015
Highest result from 2010 to 2015 net €72,502 ▲37% The operating result of €111,433 and the net result of €72,502 are both a record.
Equity above €150,000 equity €174,541 ▲71.1% After 4 profitable years in a row, equity reaches €174,541.
Annual accounts 2014 filed PDFabbreviated format · 31 days before the deadline
2014
Equity above €100,000 equity €102,039 ▲108% After 3 profitable years in a row, equity reaches €102,039.
Annual accounts 2013 filed PDFabbreviated format · 27 days before the deadline
2013
Annual accounts 2012 filed PDFabbreviated format · on the deadline day
2012
Back to profit net €33,102 The net result is €33,102, after 2 loss-making years.
Annual accounts 2011 filed PDFabbreviated format · 28 days before the deadline
2011
Annual accounts 2010 filed PDFabbreviated format · 29 days before the deadline
2009
is in office as manager PDF
IncorporationFounded by ; · Founding capital of €25,000, 100 shares · appointed as statutory manager4 points ▸
- Founded by
- Founded by
- appointed as statutory manager
- The founding capital is €25,000, divided into 100 shares
- The deed holds 2 more points.
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank
History
On 9 January 2009 the Belgian Official Gazette published the deed of incorporation of PHARMANJE.1 In 2016 the registered office moved to Anderlecht.2 In 2016 the company was absorbed by merger into MULTIPHARMA.3